Empagliflozin Monotherapy for 12 Weeks Improves Glycemic Control in Japanese Patients With Type 2 Diabetes (T2DM)Takashi Kadowaki,Masakazu Haneda,Nobuya Inagaki,Atsushi Taniguchi, Masashi Sakamoto,Kazuki Koiwai, Henning Rattunde,Hans J. Woerle,Uli C. BroedlDIABETES(2013)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要